Conversely, individuals with relatively low levels of ACE (i.e., < 4) experienced a significant reduction in the risk of persistent insomnia when higher PCE was present (AOR = 0.93, 95% CI: 0.88–0.99). This evidence concerns the gene ACE and insomnia measurement.